Adriatic
Argentina
Asia-Pacific
Australia and New Zealand
Bangladesh
Belgique (Belgium)
België (Belgium)
Brasil (Brazil)
Bulgaria
Canada
Canada
Česká republika (Czech Republic)
Chile
中国 (China)
Colombia
Costa Rica
Србија (Serbia)
Danmark (Denmark)
Deutschland (Germany)
Ecuador
España (Spain)
Europe
France
Ελλάδα (Greece)
香港特区 (Hong Kong SAR)
Indian Subcontinent
Ireland
Israel ישראל
Italia (Italy)
日本 (Japan)
Latinoamérica
Magyarország (Hungary)
México (Mexico)
Middle East and North Africa
Nederland (Netherlands)
Norge (Norway)
Österreich (Austria)
Panama
Portugal
Paraguay
Perú (Peru)
Polska (Poland)
Российская Федерация (Russia)
Puerto Rico
Romania
Schweiz (Switzerland)
Slovenská republika (Slovak Republic)
Southeast Asia
South Africa and Sub-Sahara
대한민국 (South Korea)
Suisse (Switzerland)
Suomi (Finland)
Sverige (Sweden)
台湾地区 (Taiwan)
Türkiye (Turkey)
United Kingdom
United States
Uruguay
Україна (Ukraine)
Press releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 25, 2024
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today at the North American Spine Society (NASS) 39th Annual Meeting in Chicago the commercial launch of several...
Apr 26, 2024Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN, April 26, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in...
Jan 8, 2024Rechargeable neurostimulator joins the Medtronic Percept™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming. DUBLIN, Jan. 8, 2024...
Aug 25, 2023Inceptiv automatically and instantly adjusts therapy based on signals from the spinal cord DUBLIN, Aug. 25, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology,...
Oct 26, 2022New Medtronic Neurovascular Co-Lab™ Platform drives collaboration and connections among start-ups, physicians, and institutions; aims to improve stroke treatment and access for patients...
-
Jul 14, 2022
Powered by a database of over 10,000 surgical cases, Medtronic continues to evolve the UNiD™ platform to help surgeons plan procedures, personalize care for their patients and predict...
-
May 13, 2022
Acquisition adds innovative bioabsorbable steroid-eluting sinus implants to ENT portfolio DUBLIN and MENLO PARK, Calif., May 13, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in...
-
Mar 24, 2022
TITAN 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy DUBLIN, March 24, 2022 /PRNewswire/ -- Medtronic plc (NYSE:...
Mar 23, 2022Medtronic and Harris Poll survey finds 4 in 5 report chronic back or leg pain is worse or unimproved since the COVID-19 pandemic began DUBLIN, March 23, 2022 /PRNewswire/ -- A new survey...
Feb 28, 2022Single-use device treats Eustachian tube dysfunction during office proceduresMedtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the launch of the NuVent™ Eustachian tube dilation balloon, which has been cleared by the U.S. Food and Drug...
-
Feb 22, 2022- New InterStim X™ system provides 10 to 15 years of battery life without the need to recharge
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it received approval from the U.S. Food and Drug Administration (FDA) for InterStim X™ ― the next generation...
-
Jan 24, 2022Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration approval of its Intellis™ rechargeable neurostimulator and...
Jan 14, 2022DTM™ SCS endurance therapy enables long-lasting recharge-free performance on Vanta™ and 5-minute recharge on Intellis™ neurostimulators DUBLIN, Jan. 14, 2022 /PRNewswire/ -- Medtronic plc...
-
Jan 12, 2022
Sessions will include DTM™ SCS endurance therapy 3-month outcomes for patients with chronic back and leg pain DUBLIN, Jan. 12, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in...
-
Dec 13, 2021Study shows 57.1% of patients discontinued or reduced oral opioid prescription refills post-procedure and exhibited a decrease in payer costs¹
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the results of a study published in Osteoporosis International that demonstrate a decrease, and in some cases...
-
Sep 30, 2021Industry Leading Portfolio of Integrated Solutions Sets a New Standard for Minimally Invasive Spine Procedures, Beginning with MIS+ TLIF
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the latest additions to its minimally invasive spine surgery ecosystem, making it the only company to combine...
-
Sep 28, 2021- Portfolio Features First Catheter Specifically Designed to Allow Neurointerventionalists Radial Artery Access, Delivers Advantages to Patients Treated for Stroke, Brain Aneurysms, Other Neurovascular Conditions
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE Mark approval for its radial artery access portfolio, which includes the Rist™ 079 Radial...
-
Sep 22, 2021Medtronic Will Move to Request Litigation Proceedings Resume
Medtronic (NYSE:MDT), the global leader in medical technology, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has affirmed an additional...
-
Sep 22, 2021
As First Patient Is Enrolled in the Clinical Trial of Braive™ Growth Modulation System, Study Reaffirms Medtronic's Commitment to Pediatric Spine Innovation DUBLIN, Sept. 22, 2021 /PRNewswire/...
-
Sep 13, 2021Medtronic Receives Affirmation of Three Additional Sacral Neuromodulation Patents
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has won three additional important victories in a dispute over its intellectual property (IP) for its sacral...
-
Aug 6, 2021Acquisition to Add Innovative Bioabsorbable Drug Release Platform to Chronic Rhinosinusitis Portfolio
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has entered into a definitive agreement with Intersect ENT (NASDAQ: XENT), a global ear, nose, and throat...
Jun 10, 2021Vanta™ Implantable Neurostimulator Offers Up to 11 Year Battery Life and Personalized Pain ReliefMedtronic plc (NYSE: MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for Vanta™, a high performance recharge-free...
Jun 7, 2021The SenSight™ Directional Lead System Was Designed to Enable Precision, Personalization and Enhanced Patient ComfortMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) approval and first U.S. implants of the SenSight™ Directional Lead...
-
Jun 3, 2021Compatibility of UNiD™ Rods with Medtronic's Spinal Systems Enables the Integration of AI-Driven Surgical Planning, Patient-Specific Spinal Implants and Robotic Assisted Surgery to Improve Procedural Efficiency, Precision and Outcomes
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) clearance of patient-specific UNiD™ Rods for use with Medtronic CD...
May 5, 2021New App Developed in Partnership with Higgs Boson Health, a Physician-Led Digital Health and Patient Engagement Solutions ProviderMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced CareGuidePro™, a mobile application and web portal that serves as a virtual guide for patients throughout their...
-
Apr 27, 2021New Investigational Device Aims to Expand Access to Therapy for Patients with Incontinence; Underscores Medtronic's Leadership as Only Company to Offer Neuromodulation Options for Incontinence
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced approval from the U.S. Food and Drug Administration (FDA) to proceed with an investigational device exemption...
-
Apr 26, 2021SyncAR™ Technology Uniquely Integrates with StealthStation™ S8 Surgical Navigation System and Expands the Use of Augmented Reality Into Operating Rooms to Enhance Precision and Efficiency
Medtronic plc (NYSE:MDT), the global leader in medical technology, and Surgical Theater today announced a partnership to interface Surgical Theater's SyncAR™ augmented reality (AR) technology...
-
Apr 21, 2021
First Patient Receives New Shield Surface Modification, An Advance in Flow Diversion Therapy, at NYU Langone Health DUBLIN, April 21, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global...
-
Mar 22, 2021
This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing DUBLIN, March 22, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in...
Mar 17, 2021Revised Commercial Labeling to Reflect Outcomes of a Randomized Controlled Trial Demonstrating Superiority of DTM™ Spinal Cord Stimulation (SCS) Compared to Conventional SCS for the Treatment of Chronic Intractable Back PainMedtronic plc (NYSE: MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) has approved revised commercial labeling for the Intellis™...
-
Feb 18, 2021
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration (FDA) for expanded MRI labeling of...
-
Feb 16, 2021
Dr. Gregory Poulter of OrthoIndy, Dr. Sharad Rajpal of Boulder Neurosurgical & Spine Associates and Dr. Eiman Shafa of Twin Cities Spine Center Are First in the U.S. to Complete Surgeries Using...
-
Feb 1, 2021
Acquisition of RIST Neurovascular Enhances Medtronic's Capabilities to Serve Patients Treated for Brain Aneurysms and Other Neurovascular Conditions DUBLIN, Feb. 1, 2021 /PRNewswire/ -- Medtronic...
-
Jan 14, 2021
ADAPT-PD Global Study Designed to Demonstrate Safety & Efficacy of Automated Therapy Which Responds to Brain Signals in Parkinson's Disease Patients DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Medtronic...
Dec 15, 2020The OPuS One Clinical Study is the largest study with the most meaningful clinical results supporting the OsteoCool™ Technology to-dateMedtronic plc (NYSE: MDT) today announced the release of outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation (RFA) System in the OPuS One Clinical Study (as...
-
Nov 16, 2020
Acquisition Expands Medtronic's Artificial Intelligence and Data Capabilities, Becoming the First Company to Offer an Integrated Spine Solution Including AI-Driven Surgical Planning, Personalized...
-
Oct 29, 2020New Technologies Address Most Common Challenges During Head and Neck Surgery
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital™ nerve monitoring...
Oct 20, 2020Study Reports 84% Back Pain Responder Rate and 69% Profound Responder Rate at 12 Months(1)Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced statistically significant 12-month results from a large, multicenter randomized controlled trial (RCT) that...
Oct 7, 2020A World's First That Combines Innovative Technologies: Titan nanoLOCK™ Surface Technology and NavigationMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. launch of Adaptix™ Interbody System, the first navigated titanium implant with Titan nanoLOCK™...
-
Oct 6, 2020ELITE is the Only Study of a Rechargeable Sacral Neurostimulation System to Include All Four Indications, Including Fecal Incontinence, Which Affects Millions
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first patient was implanted in its ELITE study of the InterStim™ Micro system — the only study of a...
-
Sep 25, 2020U.S. Patent and Trademark Office Rejects IPR Challenge to Medtronic Patent
Medtronic (NYSE:MDT) has won an important victory in a patent dispute over intellectual property for its sacral neuromodulation device family, the InterStim™ systems. The Patent Trial and Appeal...
-
Aug 20, 2020ELITE Study Designed to Confirm Long-Term Safety, Efficacy and Patient Benefit of Sacral Neuromodulation with the InterStim™ Micro System for Treatment of Overactive Bladder, Fecal Incontinence and Non-Obstructive Urinary Retention
DUBLIN, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has begun recruitment of the prospective, multicenter, global,...
-
Aug 5, 2020First Patient Receives New Sacral Neuromodulation Device Implant at Cleveland Clinic
DUBLIN, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that its recently FDA-approved InterStim™ Micro neurostimulator for...
-
Aug 3, 2020World’s Smallest Rechargeable Bladder/Bowel Control System — InterStim Micro — Features Trusted MRI Technology for Full-Body 1.5 and 3 Tesla MRI Scans
DUBLIN, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug...
-
Jul 15, 2020Medtronic Will Become the First Company to Offer an Integrated Solution Including Artificial Intelligence-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery
DUBLIN and LYON, France, July 15, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader in medical technology, and Medicrea (Euronext Growth Paris: FR0004178572 – ALMED Medicrea;...
-
Jun 25, 2020Next-Generation Technology Makes Percept™ the First and Only DBS System with Ability to Capture Patient-Specific Brain Signals
DUBLIN, June 25, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announces it received Food and Drug Administration (FDA) approval for the...
-
Feb 25, 2020
DUBLIN, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 40th Annual Cowen and Company Healthcare...
-
Feb 13, 2020Acquisition Will Accelerate Medtronic’s Strategy to Provide AI and Data Within Laparoscopic and Robotic Assisted Surgery
DUBLIN, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the acquisition of Digital Surgery, a privately-held pioneer in...
-
Jan 23, 2020Efficio Software Provides Enhanced, Secure Access to Patient Data and Delivers
DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal...
-
Jan 21, 2020At Three-Months, 80% of Patients Treated with DTM SCS Reported Back Pain Relief of at Least 50%; 63% Reported Profound Back Pain Relief of 80% or Greater1
DUBLIN, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced three-month results from a large, multicenter randomized controlled trial (RCT) showing statistically significant...
-
Jan 16, 2020Pediatric Health System First to Use Groundbreaking Cranial Robotic System in a Patient Surgery
DUBLIN and PHOENIX, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Nationally ranked pediatric leader, Phoenix Children’s Hospital, is the first-ever health system in the U.S. to receive and deploy the newly...
-
Jan 13, 2020Full-Body MRI-Conditional InterStim II and InterStim Micro Systems Offer Lifestyle-Friendly Choices in Sacral Neuromodulation Therapy to Europeans Suffering from Incontinence
DUBLIN, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received CE Mark for its InterStim™ Micro neurostimulator and InterStim™ SureScan™ MRI leads —...
-
Jan 9, 2020This Next-Generation DBS Technology Allows Physicians to Review Patient-Specific Brain Signals, Enabling More Personalized, Data-Driven Neurostimulation Treatment for Patients
DUBLIN, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the CE (Conformité Européenne) Mark for Percept™ PC neurostimulator; it is the only Deep Brain Stimulation...
-
Jan 8, 2020Randomized Control Trial Results to be Presented at NANS Jan. 23-26 in Las Vegas; New, Proprietary Differential Target Multiplexed (DTM) Therapy Available on Medtronic Intellis Spinal Cord Stimulation Platform
DUBLIN, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced it has acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel...
-
Dec 18, 2019Robotic Trajectory Guidance Platform Integrates Multiple Enabling Technologies to Support Complex Cranial Procedures
DUBLIN, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced that the U.S. Food and Drug Administration (FDA) recently cleared the Stealth Autoguide™ system, the first cranial...
-
Nov 4, 2019Action Seeks Relief to Prevent Further Infringement of Medtronic Patents
DUBLIN, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Medtronic, Inc. (NYSE:MDT) today filed a lawsuit against Axonics Modulation Technologies, Inc. (“Axonics”) alleging infringement of patents related to...
-
Oct 30, 2019System Offers at Home Therapy Management for DBS patients Using Patient-Friendly Consumer Technology
DUBLIN and SAN JOSE, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the U.S. launch of its advanced Patient Programmer technology for Deep Brain Stimulation...
-
Oct 7, 2019Smaller, Rechargeable Device Will Provide More Choices for Patients Suffering with Bladder and Bowel Control Issues
DUBLIN, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has filed a pre-market approval (PMA) supplement with the United States Food and Drug Administration (FDA) for...
-
Sep 26, 2019Medtronic Continues to Invest in Scientific Evidence for Expansion of Indications and Greater Clinical Understanding of Infuse™ Bone Graft
DUBLIN and CHICAGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced U.S. FDA approval of a prospective, randomized pivotal clinical trial for the use of Infuse™ Bone...
-
Sep 24, 2019Delivers the Industry’s Most Complete Portfolio of Implants, Biologics, Imaging, Navigation, Robotics, and Surface Technologies Designed to Transform Spine Outcomes
DUBLIN and CHICAGO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of several new procedural solutions for spine surgery, further reinforcing the...
-
Sep 16, 2019Pathway Helps Physicians Better Identify Which Patients to Treat with Vertebral Augmentation, Which to Manage with Conservative Care
DUBLIN, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the National Osteoporosis Foundation (NOF) supports the VCF Care...
-
Jul 22, 2019Technology Has the Potential to Save Crucial Time and Increase Access to Lifesaving Stroke Treatments
DUBLIN and SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader in medical technology, and Viz.ai, the emerging leader in applied artificial intelligence (AI)...
-
Jun 27, 2019Acquisition Accelerates Medtronic’s Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions
DUBLIN, June 27, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader in medical technology, today announced it has completed the acquisition of Titan Spine, a privately-held...
-
May 9, 2019
(GLOBE NEWSWIRE via COMTEX) --Acquisition Further Accelerates Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions DUBLIN - May 9, 2019 -...
-
May 7, 2019To Assess the Potential of Non-Opioid Treatment Options for Chronic Pain, Study Evaluates Pain Relief, Patient Function and Satisfaction
DUBLIN and LAS VEGAS - May 7, 2019 - Medtronic plc (NYSE:MDT) today announced primary endpoint (3-month) results of the Vectors Post Market Clinical Study that demonstrated effective pain relief...
-
Apr 30, 2019System Offers New Options for Improving Outcomes in Treating Stroke; World's Second-Leading Cause of Death, Third-Leading Cause of Disability
DUBLIN - April 30, 2019 - Medtronic plc (NYSE:MDT) today announced the U.S. launch of the Solitaire(TM) X Revascularization Device - and its first use in patients for the treatment of acute...
-
Apr 8, 2019Savings Are Driven by Fewer Inpatient Visits, Shorter Inpatient Length of Stay, and Fewer Emergency Department Visits
DUBLIN - April 8, 2019 - Medtronic plc (NYSE:MDT) today announced results of a study published in JAMA Network Open that demonstrates a reduction in health care utilization and cost for cancer...
-
Feb 28, 2019Grafton(TM) DBM Product Will Provide More Options for Spine and Orthopedic Surgeons in Japan
DUBLIN and TOKYO - February 28, 2019 - Medtronic plc (NYSE:MDT) announced today the Japanese launch of the Grafton(TM) Demineralized Bone Matrix (DBM) bone grafting product for spine and...
-
Feb 27, 2019Medtronic Expands Pain Portfolio with Minimally Invasive Therapy to Support Patients Throughout the Care Continuum
DUBLIN - February 27, 2019 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian(TM) RF ablation platform, which conducts radio...
-
Feb 20, 2019With Official Launch and First Implant, Several Health Insurers Now Consider DBS Therapy for Epilepsy a Covered Indication
DUBLIN - February 20, 2019 - Medtronic plc (NYSE:MDT) today announced both the U.S. launch of Deep Brain Stimulation (DBS) for medically-refractory epilepsy and the first commercially implanted...
-
Feb 20, 2019Medtronic EVP & RTG President Geoff Martha to Speak at Leerink Partners Global Healthcare Conference
DUBLIN - February 20, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 8th Annual Leerink Partners Global Healthcare Conference...
-
Feb 7, 2019Approval Based on Clinical Data from the PREMIER Trial - New Indication Provides Options for Patients with Small or Medium, Wide-Necked Brain Aneurysms
DUBLIN - February 7, 2019 - Medtronic plc (NYSE:MDT) announced today that it has received U.S. Food and Drug Administration (FDA) approval on an expanded indication for its Pipeline(TM) Flex...
-
Jan 28, 2019First U.S. Patients Treated Using Mazor X Stealth(TM) Edition at Norton Healthcare and Reston Hospital Center
DUBLIN - January 28, 2019 - Medtronic plc (NYSE:MDT) today announced the first U.S. patients treated with the Mazor X Stealth(TM) Edition for spine surgery following its recent commercial launch....
-
Jan 17, 2019Study Will Further Advance Understanding of Effectiveness and Tolerability of the SynchroMed(TM) II Intrathecal Drug Delivery System in Patients Who Have Weaned off Oral Opioids
DUBLIN - January 17, 2019 - Medtronic plc (NYSE:MDT) today announced the first patient enrolled in the Embrace TDD (targeted drug delivery) clinical study that will evaluate the use of the...
-
Dec 17, 2018Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence
DUBLIN - December 17, 2018 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the InterStim(TM) smart programmer for use with the InterStim system,...
-
Oct 24, 2018
(GLOBE NEWSWIRE via COMTEX) --myPTM Allows Patients to Personalize Their Treatment by Delivering On-Demand Boluses, or Drug Doses, Within Therapeutic Limits Set by Their Physician DUBLIN - October...
-
Oct 16, 2018
(GLOBE NEWSWIRE via COMTEX) --For Use with SynchroMed(TM) II Intrathecal Drug Delivery System, the Control WorkflowAims to Effectively Address Chronic Pain Without the Use of Oral Opioids DUBLIN -...
-
Sep 25, 2018
GLOBE NEWSWIRE via COMTEX) --System is Fully Integrated with Medtronic's Market-Leading Imaging and Navigation Technology to Transform Posterior Cervical Spine Surgery DUBLIN and LOS ANGELES -...
-
Sep 20, 2018Acquisition to Accelerate Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Fully-Integrated Surgical Solutions
DUBLIN and CAESAREA, Israel - September 20, 2018 - Medtronic plc (NYSE:MDT), a global leader in medical technology, and Mazor Robotics (NASDAQ:MZOR, TASE:MZOR.TZ), a pioneer in the field of...
-
Aug 16, 2018
(GLOBE NEWSWIRE via COMTEX) --Therapy Delivered via the Medtronic SynchroMedTM II Infusion System DUBLIN - August 16, 2018 - Medtronic plc (NYSE:MDT) today announced the online publication of...
-
Aug 16, 2018
GLOBE NEWSWIRE via COMTEX) --Therapy Delivered via the Medtronic SynchroMedTM II Infusion System DUBLIN - August 16, 2018 - Medtronic plc (NYSE:MDT) today announced the online publication of...
-
Jun 20, 2018
GLOBE NEWSWIRE via COMTEX) --Delivering Commitment to Find New Treatment Options for Patients Suffering from Sacral Insufficiency Fractures DUBLIN - June 20, 2018 - Medtronic plc (NYSE: MDT) today...
-
Jun 13, 2018FDA Approved, DBS Clinician Programmer Optimizes the Programming Experience By Addressing Day-to-Day Clinical Management Challenges
DUBLIN - June 13, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) recently approved its state-of-the art...
-
May 2, 2018Integrated Technologies Allow a Fully Navigated Procedure with Fewer Surgical Steps
DUBLIN and NEW ORLEANS - May 2, 2018 - Medtronic plc (NYSE: MDT) today announced the advanced SynergyTLIFSM workflow - a procedural solution for spine surgery that combines innovative technologies...
-
May 1, 2018Medtronic Receives FDA Approval for Deep Brain Stimulation Therapy for Medically Refractory Epilepsy7-Year Data from the SANTE Trial Showed Median Seizure Frequency Reduction of 75 percent in Patients with Drug-Resistant Epilepsy with Partial-Onset Seizures Receiving DBS Therapy.
DUBLIN - May 1, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval for Medtronic'
-
May 1, 2018Medtronic Announces TiONIC(TM) Technology, a Titanium 3D Printed Platform for Spine Surgery ImplantsTechnology Allows for Creation of More Intricate Implant Designs and Surface Textures
DUBLIN and NEW ORLEANS - May 1, 2018 - Medtronic plc (NYSE: MDT) today announced the launch of a titanium 3D printed platform - TiONIC(TM) Technology - that enables more complex designs and...
-
Apr 30, 2018Approval Adds Two Additional Implants to Current Spine Labeling
DUBLIN - April 30, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Infuse(TM) Bone Graft in new spine surgery indications. InfuseBone Graft is...
-
Apr 17, 2018Product Line Offers Unique, Resorbable Option for Patients with Hypervascular Tumors
DUBLIN - April 17, 2018 - Medtronic plc (NYSE: MDT) today announced its U.S. launch of OptiSphere(TM) embolization spheres, a resorbable embolic platform designed for embolization of hypervascular...
-
Apr 10, 2018
DUBLIN - April 10, 2018 - Medtronic plc (NYSE: MDT) announced today the CE (Conformité Européenne) Mark and European launch of the Visualase(TM) MRI-Guided Laser Ablation System. The Visualase...
-
Jan 16, 2018New System Expands Neurovascular Product Portfolio for the Treatment of Acute Ischemic Stroke
DUBLIN - January 16, 2018 - Medtronic plc (NYSE:MDT) today announced that the company's Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM)...
-
Jan 11, 2018Therapy Delivered via the Medtronic SynchroMed(TM) II Infusion System
DUBLIN - January 11, 2018 - Medtronic plc (NYSE:MDT) today announced the publication of results from the 'Spasticity In Stroke-Randomised Study' (SISTERS) trial in the Journal of Neurology,...
-
Jan 10, 2018SynchroMed(TM) II for Chronic Pain Is an Alternative to Systemic Opioids for Many Patients
DUBLIN - January 10, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of a new clinician programmer for use with the SynchroMed(TM)II Intrathecal...
-
Jan 9, 2018As More Physicians Seek Non-Opioid Treatment Options, the Vectors Study Will Further Advance Understanding of New Approaches to Optimal Spinal Cord Stimulation Treatment
DUBLIN - January 9, 2018 - Medtronic plc (NYSE:MDT) today announced the first patient enrolled in the Vectors Post Market Clinical Study. The study will follow patients with chronic intractable...